Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

NCT05479240 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

94

Enrollment

OTHER_GOV

Sponsor class

Conditions

Immunotherapy

Interventions

DRUG: Tislelizumab
DRUG: Capecitabine
DRUG: oxaliplatin
RADIATION: short-range radiotherapy

Sponsor

Fujian Cancer Hospital